Raiffeisen Bank International AG
BankPosition in ADAPY — Adaptimmune Therapeutics PLC
CIK 2044885
VIENNA, C4
Position in ADAPY
as of Dec 31, 2025
· filed Feb 12, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
5 quarters on record
Common Shares in ADAPY Over Time
Shares Held
Position Value (USD)
Derivatives in ADAPY
reported options exposure · as of Dec 31, 2025CallValue
$23
CallShares
907
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Raiffeisen Bank International AG holds $103,697,949 across 27 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
97,170 | $48,267,254 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
25,423 | $15,852,257 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
13,510 | $4,066,915 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
20,101 | $3,764,515 | |
| 5 | BNTX |
BioNTech SE
|
35,000 | $3,256,750 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
35,000 | $2,775,150 | |
| 7 | LEGN |
Legend Biotech Corp
|
80,000 | $2,310,400 | |
| 8 | ALLO |
Allogene Therapeutics, Inc.
|
1,100,000 | $2,288,000 |
All Filings in ADAPY
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $23 | 907 | Call | Sole | 2026-02-12 | |
| 2025-09-30 | $117 | 907 | Call | Sole | 2025-11-10 | |
| 2025-06-30 | $217 | 907 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $178 | 907 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $488 | 907 | Shares | Defined | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||